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We investigated whether a physiological marker of cardiovascular health, pulse pressure
(PP), and age magnified the effect of the functional COMT Val158Met (rs4680)
polymorphism on 15-years cognitive trajectories [episodic memory (EM), visuospatial
ability, and semantic memory] using data from 1585 non-demented adults from the
Betula study. A multiple-group latent growth curve model was specified to gauge
individual differences in change, and average trends therein. The allelic variants showed
negligible differences across the cognitive markers in average trends. The older portion of
the sample selectively age-magnified the effects of Val158Met on EM changes, resulting in
greater decline in Val compared to homozygote Met carriers. This effect was attenuated
by statistical control for PP. Further, PP moderated the effects of COMT on 15-years
EM trajectories, resulting in greater decline in Val carriers, even after accounting for the
confounding effects of sex, education, cardiovascular diseases (diabetes, stroke, and
hypertension), and chronological age, controlled for practice gains. The effect was still
present after excluding individuals with a history of cardiovascular diseases. The effects of
cognitive change were not moderated by any other covariates. This report underscores
the importance of addressing synergistic effects in normal cognitive aging, as the addition
thereof may place healthy individuals at greater risk for memory decline.
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INTRODUCTION
Aging is characterized by a combination of stability, growth, and decline of cognitive abilities
across the adult life span (de Frias et al., 2007a; Persson et al., 2016). More importantly, there is
often a prominent pattern of differential rates of change across individuals in cognitive trajectories
(Hultsch et al., 1992; Rabbitt et al., 2004; Ghisletta et al., 2012). Age-related changes also vary in
degree across different cognitive domains, with working memory, episodic memory, processing
speed, and visuospatial abilities exhibiting particular sensitivity to aging, whereas semantic memory
shows age resistance until the end of life (Flicker et al., 1993; Small et al., 2011; Ghisletta et al., 2012).
Cardiovascular and genetic factors are important determinants of individual differences in
cognitive decline. Genomic variability and cardiovascular-related health agents might underlay
and interplay with cognitive aging. Findings from associative studies are limited and inconclusive,
but some reports have found that cardiovascular risk × gene interactions can determine cognitive
variability (de Frias et al., 2007b, 2014; Raz et al., 2008; Persson et al., 2013a).
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With aging follows age-related loss of dopamine transmitters
(Volkow et al., 1996; Bäckman et al., 2006), and genetic variants
with the potential to influence dopamine levels are important
for age-related cognitive changes. Catechol O-methyltransferase
(COMT) degrades catecholamines (dopamine, norepinephrine,
and epinephrine), and thereby affects catecholamine signaling.
COMT modulates both nerve function and physiology due
to broad distribution throughout the brain and in various
peripheral tissues (Myöhänen et al., 2010). Val158Met (rs4680) is a
single-nucleotide polymorphism (SNP) in theCOMT gene (MIM
116790) that influences COMT enzymatic activity. The SNP
implies an exchange of the amino acid valine (Val) to methionine
(Met) at position 158 of the membrane-bound enzyme, and
at position 108 of the soluble enzyme. Dopamine levels in
the neocortex depend on COMT activity (Tunbridge et al.,
2004; Myöhänen et al., 2010). The Val variant in the Val158Met
polymorphism corresponds to higher COMT enzymatic activity
(Chen et al., 2004; Tunbridge et al., 2004) in the prefrontal cortex,
which presumably leads to lower synaptic dopamine levels by
increased dopamine degradation (Lachman et al., 1996; Chen
et al., 2004).
The functional COMT Val158Met polymorphism has attracted
extensive attention in relation to cognitive function. The vast
majority of studies are cross-sectional, and findings are to some
degree inconsistent. A meta-analysis comprised of 12 studies
and 1910 individuals (Barnett et al., 2007) reported small but
significant effects on the association between Val158Met and a
wide range of cognitive abilities. Advantages of homozygote
Met carriers over Val carriers in tasks of episodic memory,
spatial performance, and executive functions have been reported
(Egan et al., 2001; de Frias et al., 2004, 2005; Barnett et al.,
2007; Nagel et al., 2008; Raz et al., 2009). Greater risk for
cognitive decline has been observed in both heterozygotes and
homozygote carriers of the Val allele (Barnett et al., 2008;Wishart
et al., 2011). In contrast, carriers of the Val allele have shown
greater recall accuracy on tasks of episodic (O’Hara et al., 2006)
and working memory (Wang et al., 2013). Studies have also
shown little or no association between cognition and Val158Met
(Barnett et al., 2008; Wardle et al., 2013). Variations in results
may emerge from differences in study design and sampling
procedures, but the presence of uncontrolled so-called third
variables acting as moderators may also influence these effects.
Important candidates for a moderator variable approach are
cardiovascular risk factors (de Frias et al., 2007b, 2014; Raz
et al., 2008; Persson et al., 2013a). The effects of the Val158Met
polymorphism on cognition may also gain attention in older
adults and individuals already at risk for cognitive decline (de
Frias et al., 2005; Nagel et al., 2008; Josefsson et al., 2012;
Papenberg et al., 2014).
Several studies have associated cognitive decline with a
poorly controlled blood pressure (Waldstein, 2003; Waldstein
et al., 2008; Persson et al., 2013b). COMT is a candidate
gene for hypertension (Friese et al., 2011) since degradation of
catecholamines plays a critical role in the regulation of vessel
tone and blood pressure (Jordan et al., 2002; Guyenet, 2006).
Experimental work show lower activity of membrane-bound
COMT in the brain of spontaneously hypertensive rats (Masuda
et al., 2006). Findings from epidemiological studies are somewhat
inconclusive, linking the Val allele with hypertension and systolic
blood pressure elevation (Hagen et al., 2007; Kamide et al., 2007).
Counteracting has also carriers of the Met/Met allelic variant
evidenced higher systemic blood pressure in alcohol dependents
and female volunteers (Stewart et al., 2009; Yeh et al., 2010). Also,
negative findings have been reported concerning pregnancy-
induced hypertension (Sun et al., 2004).
The potential dual influence of COMT availability through
dopaminergic regulatory pathways on cerebral dopamine levels
and blood pressure regulation (Jose et al., 2003; Zeng et al.,
2007) makes it interesting to examine potential interactive
effects of blood pressure and allelic variants in the Val158Met
polymorphism. Pulse pressure (PP) combines information about
systolic and diastolic blood pressure, and is regulated by large
arteries such as the aorta. The efficiency of PP is regulated by
a degree of vascular stiffness (Safar et al., 2003) that influences
vascular tone (Steppan et al., 2011), making it attractive as a blood
pressure marker for this study.
A series of multiple-group latent growth curve models
(MGLGCM), gauging both average trends across the population
and differential growth rates of change across three domains—
episodic memory (EM), visuospatial ability, and semantic
memory—were specified to address the following research
questions: (1) Do the allelic variants differ in rates of cognitive
change? (2) Can pulse pressure (PP) elevation and older age
magnify the influence of the Val158Met polymorphism on
cognitive change? The confounding effects of years of education,
sex, and cardiovascular diseases (CVDs), as well as chronological
age and practice effects were accounted for. The MGLGCMs
allow for evaluation of potential covariate interactions, enabling
us to simultaneously rule out the potential confounding effects




Written informed consent was obtained from all participants,
and the study was approved by the regional ethics committee
in Umeå, and performed in accordance with the Declaration of
Helsinki. A sample of adults ranging from 35 to 85 years old
at the first measurement occasion was drawn from the Betula
study (Nilsson et al., 1997). The Betula study focused onmemory,
aging, and dementia in a sequential cohort, where new samples
were added at each wave. The participants were randomly
drawn from the Swedish population registry. Subjects were
tested, interviewed, and medically examined on five occasions
(1988–1990, 1993–1995, 1998–2000, 2003–2005, and 2008–2010;
Nilsson et al., 1997; Persson et al., 2013a,b).
The baseline data collection for sample 1 started in 1988,
baseline data for sample 3 was collected in 1993–1995, and
participants in this study had repeat measurements on four
occasions separated by 5 years. We recruited subjects from
samples 1 and 3, since equivalent longitudinal data were available
from these two samples. The original sample consisted of 1966
individuals.
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We wanted to study the course of aging in healthy adults
free from neurodegenerative diseases. Therefore, we excluded all
participants who met the clinical criteria for dementia according
to the Diagnostic and Statistical Manual of Mental Disorders
(DSM IV, 1994) at the most recent data collection (time point
5; n = 278). An additional 103 persons were excluded due to
missing genetic information (laboratory failure, non-compliance,
or lost blood samples). The final sample consisted of 1585
subjects (Met/Met= 494, 31.2%; Val= 1091, 68.8%).
Cognitive Measures
The cognitive tasks were administered in the same way at all
measurement occasions. Participants were individually tested
during two test sessions, which lasted between 1.5 and 2 h for each
participant. Five tasks of verbal episodic memory were used as
manifest indicators in a multivariate latent growth curve model.
Two individual tests were used to gauge semantic memory and
spatial ability.
Episodic Recall
The tasks included in the Betula study were rooted in extant
theories of memory (Tulving, 2001), and were designed for the
study but evaluated and tested in previous experiments, showing
moderate to high reliability and stable coefficients (Nyberg et al.,
2003). Structural equation models conducted on the Betula
samples have shown good construct validity for episodic memory
(Nyberg, 1994; Nyberg et al., 2003). Subjects were presented with
four different wordlists, each including 12 nouns. The items were
read aloud at a pace of two sec/item. Afterward, subjects repeated
as many words as possible at a given pace (two sec/word),
counted out by a metronome. For one list, the study/retrieval
was performed under full attention. Study retrieval in the other
lists was combined with performing a secondary task. This task
consisted of sorting red and black cards into piles based on
color. In one task, attention was divided during study but not
during retrieval. In another task, the distraction was applied
during retrieval but not during study. In the final task, distraction
occurred both during study and retrieval. The order between
the four conditions was balanced. Further, tasks of source
recall were included where the participants were asked to recall
whether sentences had been presented as subject-performed
or verbal.
Visuospatial Ability
The block design (BD) test from the Wechsler Adult Intelligence
Scale (Wechsler, 1981) was used as an indicator of spatial ability.
The participants were asked to place red and white blocks such
that they were in line with a two-dimensional target pattern.
The correct response was identical to the criterion figure, but
three-dimensionally rotated in space. The maximum score was
51 points. The task was administered and scored according to
standard instructions (Wechsler, 1981).
Semantic Memory: Vocabulary
SRB:1 (Dureman, 1960), a test of vocabulary (Vo), was treated as
a proxy for semantic memory. SRB:1 is a multiple-choice test of
word synonyms, containing 30 items with an administration time
of 7min. The test was scored according to SRB:1 criteria. For a
full description of the cognitive tasks in the Betula study (see e.g.,
Nilsson et al., 1997; Persson et al., 2013a,b).
Self-Rated Cardiovascular Health and
Medication
A self-reported questionnaire about physicians’ diagnoses was
used to assess cardiovascular health. Responses were coded as
“yes” or “no” with respect to the presence of hypertension,
diabetes, and stroke. Further, self-reported information about
the use of anti-hypertensive medication (ACE inhibitors,
beta-blockers, alpha-blockers, diuretics, and calcium channel
blockers) at baseline was included. Subjects were considered
hypertensive in the presence of a physician’s diagnosis and/or if
they were currently using anti-hypertensive medication, in order
to include participants with medically controlled hypertension.
An index variable ranging from 0 to 3 was created. All the
variables were inter-correlated and ranged from r = 0.080, p =
0.0001 to r = 0.158, p = 0.0001).
Blood Pressure
Resting blood pressure was obtained using auscultation after
5min of rest in the supine position, and registered to the nearest
five mmHg. Pulse pressure (PP), i.e., the difference between
systolic and diastolic blood pressure, was then calculated.
Genotyping of COMT Val158Met
Genomic DNA was isolated from whole blood with a Qiagen
Genomic DNA Purification Kit (Qiagen, Chatsworth, CA, USA).
Polymerase chain reactions were performed using HotstarTaq
polymerase (Qiagen) in a total volume of 20µL containing
1.5mM MgCl2, 0.15µM primers (fw: 50-TCA CCA TCG AGA
TCA ACC CC-30, rev: 50-ACA ACG GGT CAG GCA TGC
A-30), and ∼50 ng of genomic DNA. After an initial 15min
denaturation step at 95◦C, 45 cycles were performed including
30 s at 94◦C, 30 s at 62◦C, and 30 s at 72◦C. PCR products were
genotyped with a Pyrosequencer PSQ 96 and a PSQ 96 SNP
Reagent Kit (Pyrosequencing, Uppsala, Sweden; Nordfors et al.,
2002), using the sequencing primer 50-TGG TGG ATT TCG
CTG-30.
STATISTICAL ANALYSES
Latent Growth Curve Modeling
The term growth curve analysis represents the process of
describing, testing hypotheses, and making inferences about
growth and change patterns of time-related phenomena
(McArdle and Grimm, 2010). Individual differences in change
are defined by latent variables (Muthén and Curran, 1997; Frank
et al., 2007). Roughly speaking, such models capture both fixed
effects describing average trends across the population, and latent
or random effects that reflect a random probability distribution
around that fixed effect (Curran et al., 2010). The simplest forms
of latent growth curve models (LGCMs) are univariate with two
latent variables: initial level (intercept) and growth rate over
time (slope; see Figure 1; Curran and Muthén, 1999). The two
latent variables are represented by a single indicator of repeated
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measures (see Figure 1). In cases of multiple indicators, a
second-order growth model (see Figure 2) can be specified, where
changes in the first-order latent variables (common factors) are
FIGURE 1 | The triangle indicates that the model includes means and
intercepts. The latent variable variables η1 represents the intercept and η2
the slope. The model has a mean slope (κ2), and an intercept (κ1). 81,182,2
denote variances in intercept and slopes, and 81,2 covariance between the
intercept and slope. X1-4 is the manifest indicators’ repeated measures. In our
application, either repeated measures of the Vocabulary and Block Design
tasks are plugged in. θε1,1−4,4 represent the residuals of the measured
variables. Intercepts of the manifest indicators are omitted from the path
diagram.
carried by the second-order latent variables representing the
intercept and slope (see Figure 2).
Multiple-group latent growth curve models (MGLGCMs) can
simultaneously derive parameter estimates across groups and
test the equivalence of measures. If an unconditional growth
model is fitted to the pooled sample, the parameters that define
the growth model are precisely equal across groups. When the
grouping variable is added as a covariate, this will only introduce
differences in the conditional means of the growth factors such
that one of the groups will start higher or lower compared
with the other and increase more or less steeply (DSM IV,
1994; Nyberg, 1994; Nyberg et al., 2003). Further, underlying
differences in variances between groups may introduce bias
into the parameter estimates. MGLGCM can address this issue
(Curran et al., 2010; Curran and Muthén, 1999), as it performs
simultaneous estimation of growth models across two or more
groups. The presence of interactions can be examined in the
context of MGLGCM by constraining and freeing parameter
estimates across groups, and also by evaluating constraints by
changes in model fit (Meredith, 1993; Gregorich, 2006; Persson
et al., 2015).
Model Specification
A series of models were evaluated following five steps: (1)
estimation of longitudinal factor models to establish equivalence
FIGURE 2 | A path diagram illustrate the second-order growth model, where η1-4 represents the latent construct Episodic Memory, over four time
points, with four occasions of measurement, and five observed variables of verbal episodic memory at each measurement occasion. The second order
variables ξ1 represents the intercept and ξ2 the slope. The triangle indicates that the model includes means and intercepts. The model has a mean slope (κ2), and an
intercept (κ1). ψ, represent the variance of the latent variable. The average intercept is constrained in group 1 for identification (0g1). Further do 81,182,2 denote
variances in intercept and slopes, and 81,2 covariance between the intercept and slope. θ1,1−20,20 are the residuals of the measured variables. Unique covariances
and intercepts of the manifest indicators are omitted from the path diagram for parsimony.
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of measures over time and across groups; (2) one-group analyses
were performed on Met/Met and Val carriers, respectively, to
evaluate the optimal fitting functional form within each group,
and to unravel the presence of differential rates of change;
(3) two-group analysis, including the Met/Met and Val groups
simultaneously; (4) covariates were added to the models in the
presence of significant variance; and (5) interaction was evaluated
based on the fit of the parameter equality constraints.
To test if the same metric held over measurement occasions
and across allelic groups, we first tested if there was substantial
loss-of-model fit in comparing longitudinal factor models
with free parameters to models with weak-to-strong factorial
invariance (Meredith, 1993; Gregorich, 2006; McArdle, 2009).
Unconditional growth models were estimated to establish that
the shape of growth curves was similar across the two groups.
To determine the shape of the trajectory, a non-linear functional
form was estimated by a latent basis model where a random slope
was specified to be free from the second measurement interval,
in addition to a linear model (Meredith and Tisak, 1990; Grimm
and Ram, 2009a,b). The models were nested and compared by
means of chi-square goodness-of-fit indices. In both models, the
slopes were centered at the first time point (T1).
Growth factors were specified for intercept and slope,
considering both mean and individual variation, and covariance
between initial levels (intercepts) and slopes. The growth factors,
residuals, and correlated uniquenesses were allowed to vary
across groups. The conditional mean was constrained in the
reference group (Met/Met carriers) for model identification.
Univariate growth models were arranged for repeated measures
of vocabulary (Vo) and block design (BD) scores (see Figure 1).
A psychometric model was specified to represent the episodic
memory (EM) with a second-order growth model, comprised of
four occasions of repeated measures of five observed variables of
verbal recall.
Differences in average cognitive change rates between the
allelic variants were tested to evaluate equality of parameters
across groups using the Wald Test of Parameter Constraints.
Conditional growth models were specified for the cognitive
domains showing significant individual variance in cognitive
trajectories. Based on the existing literature supporting a Val
dominant model in relation to cognitive function (de Frias
et al., 2004, 2005; Barnett et al., 2008; Wishart et al., 2011)
and lower enzyme activity in Met carriers compared to Val
carriers (Lachman et al., 1996), we divided the sample into two
groups comprised of Met homozygotes and Val heterozygotes.
The confounding effects of years of education, sex (women =
1), and cardiovascular diseases (CVDs) were controlled in the
analyses. Further, pulse pressure (PP) and chronological age were
grand-mean centered and used as continuous time-invariant
covariates. To avoid underestimation of age-related changes, we
estimated retest effects by a retest variable coded 0, 1, 2, or 3 (0 for
baseline; Ferrer et al., 2005; Ghisletta et al., 2014). The presence
of interaction was tested by evaluating equality constraints on
the age slope using the difference in χ2 (1χ2 = χ2restricted −
χ2unrestricted, with df = df restricted − df unrestricted; Persson et al.,
2015). A set of follow-up analyses was also performed on a
subsample of participants free of CVDs (n = 1086).
Evaluation of the models fit to the data was done using
conventional cut-off criteria from several fit indexes: the
Comparative Fit Index (CFI)> 0.95, the Standardized RootMean
Square Residual (SRMR) < 0.08, and the Root-Mean-Square
Error of Approximation (RMSEA) < 0.08 (Browne and Cudeck,
1993; Hu and Bentler, 1998, 1999), in addition to the χ2 test with
its degrees of freedom (df ). We assumed that data were missing
at random, and parameter estimates were obtained using full
information maximum likelihood (FIML) estimation (McArdle
and Nesselroade, 1994; Little, 1995). In FIML, parameters are
estimated based on all available data, and the key assumption is
that the missing data are missing at random (MAR). Auxiliary
variables related to the missingness mechanism were included
in the analyses to further reduce estimation bias (Collins et al.,
2001).
RESULTS
Descriptive Statistics and Correlations
Descriptive statistics are presented in Supplementary Tables
1, 2. The genotype distribution of the COMT Val158Met
polymorphism among the 1585 subjects conformed to Hardy-
Weinberg equilibrium (χ2 = 0.022, p = 0.881), with 31.2% being
Met/Met carriers, 19.7% being Val/Val carriers, and 49.1% being
Val/Met carriers. Prior to the analyses, we identified potential
outliers by Tukey upper and lower fences, multiplied by a factor
of 2.2 [3Q (3rd quartile)+ 2.2× IQR (inter-quartile range)], and
1Q - 2.2 × IQR (Hu and Bentler, 1999). Ten univariate outliers
in blood pressure were eliminated. The vocabulary (Vo) tasks
exhibited negative skew (skewness from−1.248 to−1.454).
In homozygote Met carriers, the correlations of stability
among variables ranged from r = 0.317 for source recall over
T1-T4 to r = 0.507 over T1-T2 for full attention retrieval. The
correlations for visuospatial ability, measured by a single task
[block design (BD)], ranged from r = 0.736 over T1-T4 to
r = 0.812 over T1-T2, and for Vo scores (a proxy for semantic
memory) from r = 0.824 over T1-T4 to r = 0.855 over T1-T2
among the Met/Met carriers.
For Val heterozygotes, correlations between measurement
occasions ranged from r = 0.237 for source recall over T1-T4 to
r = 0.438 over T1-T2 for full attention retrieval. The correlations
for BD ranged from r = 0.736 over T1-T4 to r = 0.813 over T1-
T2, and for Vo scores from r = 0.856 over T1-T2 to r = 0.856
over T1-T2 in the Val group.
Logistic regressions were carried out to examine potential
causes of attrition. Men (B = −0.318, SE = 0.139, p = 0.022)
and older individuals (B = 0.041, SE = 0.007, p = 0.001) were
more likely to drop out, after accounting for pulse pressure (PP;
p = 0.375), cardiovascular diseases (CVDs; hypertension, stroke,
and diabetes; p = 0.409), years of education (p = 0.275), and
COMT allelic variation (p = 0.061).
Longitudinal Factor Models: Measurement
Invariance
To examine measurement invariance over time and across
groups, longitudinal factor models were carried out in each group
defined by allelic variant, followed by a multiple group analysis
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(2-group analysis). The factor loadings showed moderate to
strong association with the latent construct episodic memory.
The standardized factor loadings ranged from 0.466 to 0.755, in
homozygote Met carriers, and from 0.444 to 0.745 in carriers
of at least one Val allele. No substantial loss of fit was observed
when comparing the baseline model with free parameters with
the model assuming strong factorial invariance, showing good fit
to the data in homozygote met carriers [χ2(158) = 256.857, CFI =
0.966, SRMR = 0.059, RMSEA = 0.036 (90% C.I. 0.027–0.043)]
and Val carriers [χ2(158) = 402.733, CFI = 0.958, SRMR = 0.063,
RMSEA= 0.038 (90% C.I. 0.033–0.042)]. Without crucial loss of
fit compared to the free parameter models, the strong factorial
multiple group model showed good fit to the data [χ2(327) =
733.983, CFI= 0.953, SRMR= 0.070, RMSEA= 0.040 (90% C.I.
0.036–0.043)], so that measurement invariance was established
over the allelic groups.
One-Group Analyses: Functional Form of
Cognitive Trajectories and Variance
As mentioned in Section Model Specification, we tested the
functional form of trajectories by using linear or non-linear
models. The trajectory shape was best described in a linear
fashion across the allelic groups for EM and BD. The non-linear
model fit closer to the Vo data (smaller χ2, RMSEA, and SRMR
values; see Supplementary Table 3). The univariate LGCMs for
Vo and BD showed good fit to the data [CFI = 1.000, 0.998,
SRMR = 0.020, 0.037, RMSEA = 0.000, 0.038 (90% C.I. 0.000–
0.030, 0.015–0.060), χ2(10,10) = 9.733, 21.351, p = 0.4642, 0.0188].
As presented in Table 1, variance in intercepts was present across
all cognitive domains over allelic groups, but only EM scores
exhibited significant slope variance across the two allelic groups.
Consequently, determinants of individual rates of change could
be added to the EM models, but their influence on the BD or Vo
trajectories could not be evaluated.
Multiple-Group Latent Growth Curve
Models: Two-Group Analyses
The chi-square distribution for the EM model for Met/Met
carriers was 320.273, and 492.008 for Val heterozygotes. The
standardized factor loadings were moderate to strong, ranging
from 0.495 to 0.730. As presented in Table 1, the parameter
estimates of average growth rates were very similar in size across
groups, which was confirmed by the insignificant differences
between the parameters {p = n.s. [e.g., EM: 1χ2(1) = 0.407,
p = 0.5235 (Wald Test of Parameter Constraints)]}.
Determinants of Differential Rates of
Change
As mentioned previously, covariates were added selectively to
the EM model since variance in change was present in both
allelic groups. All results are presented in Table 2. When the
sample was analyzed in its entirety, we observed no magnifying
effects of age on the association between COMT and EM decline
[1χ2(1) = 1.164, p = n.s.]. However, we observed additive effects
of age on the EM slope, so that older Val carriers showed
increased decline, accounting for the demographic factors, after
(β = −0.433, SE = 0.170, p = 0.010), exclusion of the four
younger cohorts (35, 40, 45, and 50 years) [1χ2(1) = 128,327
p = 0.0001]. The association was attenuated after additional
control for cardiovascular risk factors (p = 0.130). No influence
of retest effects on the EM trajectories emerged. Women showed
higher baseline EM scores than men in both allelic variants, but
sex did not significantly differentiate growth rates in any allelic
group. Higher educational attainment influenced intercept level,
but had no effect on individual differences in change.
The presence of CVDs at baseline was reflected in lower
baseline EM scores in Val carriers, and a trend in the same
direction was present in the Met/Met group (p = 0.068).
There was no indication of magnifying effects of CVDs on the
relationship between SNP and EM [1χ2(1) = 0.285, p = n.s.].
Pulse pressure did not influence the level of EM performance
across allelic groups (e.g., Val: p = 0.020, α′ = 0.010]. Val carriers
declined in episodic memory as a function of PP elevation over
time (p = 0.002, α′ = 0.01). The interaction effect was present by
means of significant deterioration of fit by the parameter equality
constraint [1χ2(1) = 5.773, p = 0.005]. See Figure 3 for an
illustration.
Subsidiary Analyses: Subjects without
CVDs
The analyses were carried out after excluding individuals with
CVDs (stroke, diabetes, or hypertension; Val n = 751, Met/Met
TABLE 1 | Parameter estimates from the linear models, means of the initial level and growth rates, and their variances.
Met/Met Val
EM BD Vo EM BD Vo
k1 0.000 (0.000) 2.705 (0.048) 22.024 (0.244) 0.000 (0.000) 2.676 (0.032) 21.832 (0.157)
k2 −0.138 (0.017) −0.118 (0.012) 0.015 (0.053) −0.123 (0.011) −0.116 (0.008) −0.049 (0.038)
81,1 1.124 (0.112) 0.964 (0.073) 25.886 (1.894) 0.875 (0.059) 0.922 (0.048) 24.042 (1.169)
82,2 0.017 (0.008) 0.004 (0.005) 0.016 (0.113) 0.012 (0.005) 0.002 (0.004) 0.304 (0.089)
81,2 −0.023 (0.023) 0.020 (0.015) 0.252 (0.343) 0.011 (0.012) 0.040 (0.010) 0.159 (0.249)
EM, Episodic Memory; BD, Block Design; Vo, Vocabulary; k1, average intercept; k2, average slope; Φ1,1, intercept variance; Φ2,2, slope variance; Φ1,2, intercept and slope covariance;
Standard errors are presented in parentheses.
Bold faced parameter estimates indicate significance (p < 0.05).
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TABLE 2 | Covariates effects on initial level and change: Raw and standardized parameter estimates.
Met/Met Val
Level Slope Level Slope
Unst. Std. Unst. Std. Unst. Std. Unst. Std.
Age −0.028 (0.004)* −0.374 (0.047)* −0.075 (0.021)* −0.361 (0.097)* −0.024 (0.003)* −0.365 (0.038)* −0.047 (0.023)* −0.272 (0.135)*
Sex 0.465 (0.079)* 0.222 (0.037)* −0.905 (0.584)* −0.156 (0.102) 0.300 (0.047)* 0.161 (0.025)* −0.185 (0.381) −0.038 (0.078)
Education 0.048 (0.009)* 0.222 (0.041)* 0.115 (0.078) 0.194 (0.132) 0.082 (0.007)* 0.358 (0.030) 0.045 (0.056) 0.075 (0.095)
Practice 0.249 (0.038)* 0.268 (0.040)* 0.463 (0.380) 0.180 (0.140) 0.162 (0.026)* 0.187 (0.029)* 0.393 (0.376) 0.174 (0.160)
CVD −0.137 (0.075) −0.075 (0.041) −0.065 (0.606) −0.013 (0.119) −0.168 (0.047)* −0.100 (0.028)* 0.482 (0.429) 0.109 (0.099)
PP −0.003 (0.003) −0.047 (0.045) 0.013 (0.021) 0.077 (0.127) 0.004 (0.002)* 0.081 (0.032)* −0.050 (0.015)* −0.351 (0.115)*
CVD, Cardio vascular disease; PP, Pulse pressure; Sex (1 = female, 0 = Male), Practice (0–3); Age; Chronological age centered on the sample grand mean; Unst., Non-standardized
parameter estimates; Std, Standardized parameter estimates; STDYX solution. Standard errors of the parameter estimates are presented within parenthesis. *Bonferroni-adjusted
significance α′ = 0.01.
FIGURE 3 | Episodic Memory (EM) changes as a function of pulse
pressure (PP) at baseline, in Met/Met, and Val carriers respectively. PP
magnifies the effect of COMT 158Val on 15 years EM change, resulting in
greater decline in Val carriers. The expected values are calculated from the
slope factor scores, while taking into account the effects of covariates. PP in
millimeter of mercury is centered at the grand-mean.
n = 335). It is worth noting that individuals without CVDs
were younger than persons suffering from CVDs (F(3) =
110.041, p = 0.0001]. Higher levels of PP still indicated EM
decline among COMT Val carriers (β = −0.437, SE = 0.191,
p = 0.022). This interaction was confirmed by significant
deterioration of model fit [1χ2(1) = 5.773, p = 0.005].
Incremental practice effects on episodic memory growth (β =
0.354, SE= 0.140, p = 0.015) were selectively evident inMet/Met
carriers, but the slope constraint was not tenable [1χ2(1) = 2.30,
p = 0.12].
DISCUSSION
Our chief finding was that pulse pressure (PP) elevation
moderated the effect of the functional Val158Met polymorphism
on 15-years episodic memory (EM) trajectories, leading to steep
decline in Val carriers and accounting for various covariates with
the potential to affect individual differences in cognitive change.
The effect was still present when individuals with a history of
hypertension, diabetes, or stroke were excluded. To the best of
our knowledge, this is a novel finding. We further confirmed
previous reports showing that aging magnified the influence of
genetic variance in a common functional genetic polymorphism,
Val158Met, leading to greater decline of EM scores in Val carriers,
at least when potential attenuation from demographic factors was
taken into account. The effects were not moderated by any other
covariates.
Importantly, we did not detect any evidence of differences
between allelic groups in rates of change across cognitive
markers. Instead, we found that both groups conformed to
frequent reports of stability rather than change in crystalized
abilities (such as vocabulary) and average decline in fluid abilities
during aging (Horn and Cattell, 1967; Rönnlund et al., 2005;
Ghisletta et al., 2012).
Individual single nucleotide polymorphisms (SNPs) may have
little influence on complex behavioral measures such as cognitive
function, as even whole genes may exert small effects (Plomin
et al., 1994). Our results conform to findings from a large meta-
analysis that reported no association between Val158Met and a
wide range of cognitive functions (Barnett et al., 2008). The
negative findings reported herein also contradict previous reports
of allele-specific differences in EM and spatial performance scores
(de Frias et al., 2004, 2005). It is important to note that these
authors applied a single measurement interval (5 years) to a
male sample. It is possible that our findings would have been
similar if these design aspects were equivalent. Variability in task
characteristics between studies may further enhance differences
in results.
Advanced age predicted lower EM scores at inception,
followed by decay over 15 years in both allelic variants after
controlling for the potential confounding of practice effects.
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There was no indication of additive effects of age when the
sample was analyzed in its entirety. Because previous work
has illustrated that the effects of COMT may emerge in older
adults and individuals at risk for cognitive decline (de Frias
et al., 2005; Lindenberger, 2008; Nagel et al., 2008; Josefsson
et al., 2012; Papenberg et al., 2014), we performed a secondary
analysis, excluding the younger age cohorts while controlling for
demographic factors and retest effects. We indeed found support
for the additive effects of age in the older Val allelic group,
in accordance with the resource modulation hypothesis. This
hypothesis proposes that the effects of genetic polymorphisms
are magnified in older age following the reduction of brain
resources that influence cognitive functions (Lindenberger,
2008). The effect, however, was attenuated by statistical control
for cardiovascular diseases and pulse pressure. We would like
to stress the importance of further assessing the influence
of cardiovascular risk factors in age-related behavioral genetic
studies in the future.
The effects on memory were not moderated by any other
covariates. Sex did not magnify the influence of genetic risk on
episodic memory trajectories, conforming to previous negative
findings that considered the additive effects of SNPs and sex on
cognition (Ghisletta et al., 2014). Higher educational attainment
resulted in better initial EM scores across the allelic variants,
but could not reliably explain differential EM changes. The
combined influence of genetics and educational factors on
cognitive function may gain ground in the context of heritability,
likely reflecting polygenetic influences (Rowe et al., 1999) to a
greater degree than in the candidate approach of a single SNP
used in this study.
Practice gains were present on intercept levels of EM scores,
but no additional time-related practice gains were observed
across the two allelic variants after demographics and health-
related effects were taken into account. Studies have previously
reported diminishing practice gains on global cognitive function
beyond follow-up (Jacqmin-Gadda et al., 1997). Gains in EM
scores were present in theMet carriers after excluding individuals
with diabetes, stroke, and hypertension. An interaction was not
established by means of tenability of the equality constraint. This
result deserves some attention from future studies, since the
trend gives a hint of possible genomic variability differentiating
practice gains by potentially influencing neurocognitive reserve
(Satz, 1993) in carriers of lower enzyme activity alleles.
No influence of cardiovascular disease load was observed
beyond the initial level. Greater cardiovascular disease load
indicated lower initial EM scores among heterozygous Val
carriers, and a trend in this direction was also observed in Met
carriers (p = 0.068). One reason for the discrepancy in results
between cross-sectional negative impacts and absence of long-
term effects could be that participants were informed about their
health status at baseline for ethical reasons, which could have
reversed long-term cognitive decline due to lifestyle changes.
The Val allele is associated with higher COMT enzyme
availability and has previously been associated with cognitive
decline, although findings were mixed (Barnett et al., 2008;
Wang et al., 2013). Our report shows that the negative
influence of the Val allele is particularly pronounced with pulse
pressure elevation. Importantly, this effect was present even after
excluding individuals with diabetes, stroke, and hypertension,
suggesting that the effect was also crucial in healthier subjects
who would be expected to take advantage of greater cognitive
reserve by maintaining their cognitive abilities (Stern, 2003).
The underlying biomedical mechanism of these effects is
unknown. The mechanism behind the reported interaction may
emerge from various pathways. A common explanation is that
Val158Met influences cognitive function through the regulation
of dopamine levels, with Val carriers having high COMT activity
and lower dopamine levels (Lachman et al., 1996; Chen et al.,
2004). The Val allele has also been linked with high blood
pressure (Hagen et al., 2007; Kamide et al., 2007), which can
be mediated by dopamine through its influence on sodium
regulation (Jose et al., 2003; Zeng et al., 2007). Inflammation
may be another variable accounting for this effect. Inflammation
influences permeability in the vasculature (Kolattukudy and Niu,
2012) that can cause decreased blood flow to the brain, leading to
increased white matter burden (Novak et al., 2006; Kolattukudy
and Niu, 2012) that manifests as cognitive decline (Birdsill et al.,
2013). Taken together, these factors may offset episodic memory
decline.
The prodromal stage of Alzheimer’s disease is known to be
extensive (Small et al., 2003; Iacono et al., 2009), and even
if demented individuals were excluded until the last available
data collection, occasionally there may be a risk of including
individuals with early dementia.
We used pulse pressure (PP), combining information from
systolic and diastolic blood pressure, in the current report.
Combining PP with the carotid-femoral pulse wave velocity
(PWV) may have given a more precise measure of vessel tone
and vascular stiffness. Our findings would benefit from future
replication by combining such measures.
Polygenetic influences may shape episodic memory in aging,
directly and indirectly, by affecting mediators of cognitive
decline. Various genes have been proposed to influence
hypertension (Friese et al., 2011), and SNPs that affect immune
system pathways may influence verbal declarative memory
(Debette et al., 2015). Such SNPs may enhance the effects of
inflammation on aging and interact with the effects reported
herein, but unfortunately, we lacked such information. Our
findings should be replicated to enhance the generalizability of
the results, and further investigation of biomedical mechanisms
behind the effects is warranted.
To the best of our knowledge, this is the first report to
show that pulse pressure magnifies the effects of the COMT Val
allelic variant on 15-years episodic memory decline. This report
underscores the importance of addressing synergistic effects on
normal cognitive aging, as the addition thereof may also place
healthy individuals at greater risk for memory decline.
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